|
Notification of buy-back - CYC
|
16 May 2023 at 2:00pm
|
|
Results of Meeting
|
16 May 2023 at 1:59pm
|
|
Managing Director's Address to Shareholders
|
16 May 2023 at 11:50am
|
|
CYC 2023 AGM Presentation
|
16 May 2023 at 11:50am
|
|
Chairman's Address to Shareholders
|
16 May 2023 at 11:45am
|
|
Cyclopharm Confirms USFDA Scheduled Inspection Date
|
9 May 2023 at 8:40am
|
|
USFDA Confirms Technegas Six Month Review Period
|
24 April 2023 at 10:15am
|
|
Cyclopharm Acquires DuPharma ApS
|
20 April 2023 at 8:45am
|
|
Application for quotation of securities - CYC
|
18 April 2023 at 11:50am
|
|
Proposed issue of securities - CYC
|
17 April 2023 at 5:05pm
|
|
Notice of Annual General Meeting/Proxy Form
|
13 April 2023 at 12:10pm
|
|
Cyclopharm USFDA Approval Progress Update
|
5 April 2023 at 10:10am
|
|
Appendix 4G
|
31 March 2023 at 1:25pm
|
|
Annual Report to shareholders
|
31 March 2023 at 1:20pm
|
|
Technegas Enters Final Six Month USFDA Review Cycle
|
30 March 2023 at 11:20am
|
|
Application for quotation of securities - CYC
|
24 March 2023 at 12:05pm
|
|
Date of Annual General Meeting
|
15 March 2023 at 8:35am
|
|
CYC Results Summary
|
20 February 2023 at 2:45pm
|
|
Preliminary Final Report
|
20 February 2023 at 2:40pm
|
|
Dividend/Distribution - CYC
|
20 February 2023 at 2:30pm
|
|
Change of Director's Interest Notice - KBarrow
|
5 December 2022 at 8:45am
|
|
Change of Director's Interest Notice - DAngus
|
30 November 2022 at 4:35pm
|
|
Cyclopharm Receives $1.64m R&D Refund
|
29 November 2022 at 11:10am
|
|
Bell Potter Healthcare Conference Directors Profile
|
9 November 2022 at 9:55am
|
|
Bell Potter Healthcare Conference
|
9 November 2022 at 8:55am
|
|
Notification of cessation of securities - CYC
|
5 October 2022 at 4:30pm
|
|
CYC Board Changes
|
27 September 2022 at 9:35am
|
|
Initial Director's Interest Notice
|
27 September 2022 at 9:30am
|
|
Initial Director's Interest Notice
|
1 September 2022 at 8:20am
|
|
CYC Board Changes
|
1 September 2022 at 8:20am
|
|
Half Year 2022 Results
|
17 August 2022 at 8:40am
|
|
Half Yearly Report and Accounts
|
17 August 2022 at 8:35am
|
|
Dividend/Distribution - CYC
|
17 August 2022 at 8:35am
|
|
Technegas Used In Multicenter COVID Study
|
7 July 2022 at 9:15am
|
|
1H 2022 Business Update - Record Revenues
|
4 July 2022 at 10:55am
|
|
Change of Director's Interest Notice
|
14 June 2022 at 2:00pm
|
|
CYC Investor Presentation 24 May 2022
|
24 May 2022 at 10:05am
|
|
Technegas used in Diagnosing Long COVID
|
24 May 2022 at 9:20am
|
|
Change of Director's Interest Notice
|
23 May 2022 at 8:40am
|
|
Results of Meeting
|
17 May 2022 at 1:35pm
|
|
Managing Director's Address to Shareholders
|
17 May 2022 at 11:45am
|
|
CYC 2022 AGM Presentation
|
17 May 2022 at 11:40am
|
|
Chairman's Address to Shareholders
|
17 May 2022 at 11:35am
|
|
Notice of Annual General Meeting/Proxy Form
|
14 April 2022 at 10:30am
|
|
Appendix 4G
|
31 March 2022 at 2:30pm
|
|
Annual Report to shareholders
|
31 March 2022 at 2:30pm
|
|
Date of Annual General Meeting
|
16 March 2022 at 8:45am
|
|
Change of Director's Interest Notice
|
9 March 2022 at 3:10pm
|
|
S&P DJI Announces March 2022 Quarterly Rebalance
|
4 March 2022 at 5:30pm
|
|
CYC Results Summary
|
23 February 2022 at 7:05pm
|
